Table 4 Baseline laboratory measurements in study participants.
Characteristics | General (n = 163) | Intervention group (n = 81) | Control group (n = 82) | P value |
|---|---|---|---|---|
Estimated glomerular filtration rate (ml/min/1.73m2), n (%) | ||||
< 60 | 14 (8.60) | 5 (6.20) | 9 (11) | 0.27 |
≥ 60 | 149 (91.40) | 76 (93.80) | 73 (89) | |
Baseline FBG (mmol/L), median (IQR) | 7.6 (6.90–8.80) | 7.5 (6.90–8.70) | 7.8 (6.90–10.10) | 0.60 |
Baseline HbA1c (%), median (IQR) | 7.7 (7.00–8.90) | 7.8 (7.10–9.00) | 7.6 (6.90–8.80) | 0.26 |
Baseline HbA1c ≥ 7%, n (%) | 125 (76.70) | 64 (79) | 61 (74.40) | 0.49 |
Baseline LDL (mmol/L), median (IQR) | 2.2 (1.70–2.90) | 2.1 (1.70–2.90) | 2.2 (1.60–3.00) | 0.91 |
Baseline HDL (mmol/L), median (IQR) | 1.1 (0.95–1.23) | 1.1 (0.95–1.30) | 1.1 (0.95–1.20) | 0.53 |
Baseline triglycerides (mmol/L), median (IQR) | 1.8 (1.30–2.80) | 1.9 (1.40–3.00) | 1.7 (1.20–2.30) | 0.008 |
Baseline total cholesterol (mmol/L), median (IQR) | 4.2 (3.10–5.00) | 4.2 (3–5) | 4.2 (3.30–5.00) | 0.90 |
